Peroxyvanadium compounds inhibit glucose-6-phosphatase activity and glucagon-stimulated hepatic glucose output in the rat in vivo.

导出原文传递

翻译打印收藏纠错

作者： Westergaard N ^[1] ; Lewinsky RH ; Andersen HS ; Carr RD ; Burchell A ; Lundgren K ; Brand CL

作者单位： Department of Diabetes Biochemistry and Metabolism, Department of Medicinal Chemistry Research, Novo Nordisk A/S, Novo Nordisk Park, Malov, DK-2760, Denmark. NWe@Novo.dk ^[1]

关键词 Animal Dose-Response Relationship Drug Glucagon: Pharmacology Glucose: Metabolism Glucose-6-Phosphatase: Antagonists and inhibitors Insulin: Pharmacology Liver: Drug effects Liver: Metabolism Male Microsomes Molecular Mimicry Organometallic Compounds: Pharmacology Phenanthrolines: Pharmacology Rats Sprague-Dawley Vanadates: Pharmacology

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Archives of Biochemistry and Biophysics

1999年366卷1期

55-60页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Peroxyvanadium compounds inhibit glucose-6-phosphatase activity and glucagon-stimulated hepatic glucose output in the rat in vivo.

Archives of Biochemistry and Biophysics

相似文献

Archives of Biochemistry and Biophysics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Peroxyvanadium compounds inhibit glucose-6-phosphatase activity and glucagon-stimulated hepatic glucose output in the rat in vivo.

Archives of Biochemistry and Biophysics

相似文献

Archives of Biochemistry and Biophysics

相关期刊

检索历史清除